CASC8 and cancer: The strongest risk effect was found for the novel intronic variant rs16902147 in the CASC8 (cancer susceptibility candidate 8) gene at 8q24 with an OR of 1.86 (95% CI 1.56–2.23; padj = 3.53 × 10−8) and EAF of 0.07.